Faeth Therapeutics, Inc.
FTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829802
In the last 90 days, Faeth Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Faeth Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +5 vs. Q4 2021
- Shares held
- 3.55M
- +146.4K (+4.3%) vs. Q4 2021
- Total value
- $8.21M
- −$11.5M (−58.3%) vs. Q4 2021
- New holders
- 11
- 10 more added
- Sold out
- 6
- 15 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $333.8M |
| Q1 2026 | 30 | $68.0M |
| Q4 2025 | 10 | $514.8K |
| Q3 2025 | 9 | $466.2K |
| Q2 2025 | 10 | $600.0K |
| Q1 2025 | 20 | $760.2K |
| Q4 2024 | 24 | $1.16M |
| Q3 2024 | 19 | $1.32M |
| Q2 2024 | 24 | $1.31M |
| Q1 2024 | 25 | $2.43M |
| Q4 2023 | 24 | $2.05M |
| Q3 2023 | 23 | $2.38M |
| Q2 2023 | 26 | $3.58M |
| Q1 2023 | 27 | $4.71M |
| Q4 2022 | 28 | $3.93M |
| Q3 2022 | 31 | $4.47M |
| Q2 2022 | 40 | $7.06M |
| Q1 2022 | 43 | $8.21M |
| Q4 2021 | 38 | $19.7M |
| Q3 2021 | 42 | $37.1M |
| Q2 2021 | 34 | $22.7M |
| Q1 2021 | 40 | $45.8M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Faeth Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 1,168,011 | $2.70M | 0.00% | −34,718−2.9% | Reduced |
| Vanguard Group Inc | 755,950 | $1.75M | 0.00% | +2,255+0.3% | Added |
| Geode Capital Management, LLC | 255,828 | $590.0K | 0.00% | −690−0.3% | Reduced |
| State Street Corp | 225,572 | $521.0K | 0.00% | +15,280+7.3% | Added |
| JPMorgan Chase & Co | 156,365 | $361.0K | 0.00% | −3,413−2.1% | Reduced |
| Northern Trust Corp | 154,161 | $356.0K | 0.00% | −5,700−3.6% | Reduced |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 100,000 | $231.0K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 83,195 | $192.0K | 0.00% | +83,195 | New |
| Two Sigma Investments, LP | 62,184 | $144.0K | 0.00% | +33,413+116.1% | Added |
| Nuveen Asset Management, LLC | 52,456 | $133.0K | 0.00% | +909+1.8% | Added |
| Bank of New York Mellon Corp | 54,089 | $126.0K | 0.00% | −1,358−2.4% | Reduced |
| Truist Financial Corp | 50,441 | $117.0K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 50,229 | $116.0K | 0.00% | +50,229 | New |
| Millennium Management LLC | 49,744 | $115.0K | 0.00% | −37,546−43.0% | Reduced |
| Bank of America Corp | 48,001 | $110.0K | 0.00% | +22,967+91.7% | Added |
| Charles Schwab Investment Management Inc | 43,865 | $102.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 40,900 | $94.0K | 0.00% | +20,900+104.5% | Added |
| Bridgeway Capital Management, LLC | 37,900 | $88.0K | 0.00% | +37,900 | New |
| Rhumbline Advisers | 16,169 | $37.0K | 0.00% | −2,725−14.4% | Reduced |
| BFT Financial Group, LLC | 14,845 | $34.0K | 0.01% | +14,845 | New |
| UBS Group AG | 13,618 | $31.0K | 0.00% | −8,784−39.2% | Reduced |
| Raymond James & Associates | 13,000 | $30.0K | 0.00% | +13,000 | New |
| Goldman Sachs Group Inc | 12,677 | $29.0K | 0.00% | +1,579+14.2% | Added |
| Deutsche Bank AG | 11,343 | $26.0K | 0.00% | −1,340−10.6% | Reduced |
| Morgan Stanley | 11,086 | $25.0K | 0.00% | −25,760−69.9% | Reduced |
| Jane Street Group, LLC | 10,767 | $25.0K | 0.00% | +10,767 | New |
| American International Group, Inc. | 10,375 | $24.0K | 0.00% | −730−6.6% | Reduced |
| California State Teachers Retirement System | 9,107 | $21.0K | 0.00% | −2,184−19.3% | Reduced |
| Wells Fargo & Company | 7,003 | $16.0K | 0.00% | −1,780−20.3% | Reduced |
| New York State Common Retirement Fund | 5,490 | $13.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,751 | $11.0K | 0.00% | +1,128+31.1% | Added |
| Banque Cantonale Vaudoise | 3,900 | $9.00K | 0.00% | +3,000+333.3% | Added |
| Barclays PLC | 3,394 | $8.00K | 0.00% | +3,394 | New |
| FNY Investment Advisers, LLC | 3,500 | $8.00K | 0.01% | +3,500 | New |
| Amalgamated Bank | 2,516 | $6.00K | 0.00% | +2,516 | New |
| Amalgamated Financial Corp. | 2,516 | $6.00K | 0.00% | +2,516 | New |
| Citigroup Inc | 2,110 | $5.00K | 0.00% | −4,311−67.1% | Reduced |
| Legal & General Group Plc | 1,674 | $4.00K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 1,602 | $4.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,284 | $3.00K | 0.00% | −3,059−70.4% | Reduced |
| Toronto Dominion Bank | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Ellevest, Inc. | 19 | $0 | 0.00% | +1+5.6% | Added |
| FMR LLC | 179 | $0 | 0.00% | +179 | New |
| Virtu Financial LLC | 0 | $0 | 0.00% | −15,980−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −12,804−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −11,800−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −772−100.0% | Sold out |
| Investment Research & Advisory Group, Inc. | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |
| Snowden Capital Advisors LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |